Shanghai Shen Lian Biomedical Corporation
688098
Rank in Stocks
#12748
Shanghai Shen Lian Biomedical Corporation operates within China's animal health... Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.
Share Price
$1.08
Last synced: 2026-11-10
Market Cap
$443.70M
Change (1 day)
-0.14%
Change (1 year)
-28.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shanghai Shen Lian Biomedical Corporation (688098)
Category
Healthcare
Operating Margin for Shanghai Shen Lian Biomedical Corporation (688098)
Operating Margin as of November 2026 TTM: -12.23%
According to Shanghai Shen Lian Biomedical Corporation's latest financial reports, its current operating margin (TTM) is -12.23%. At the end of 2025 the company had an operating margin of -10.98%.
Operating Margin history for Shanghai Shen Lian Biomedical Corporation from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -12.23% | 11.38% |
| 2025 | -10.98% | -41.03% |
| 2024 | -18.62% | -255.43% |
| 2023 | 11.98% | -47.69% |
| 2022 | 22.90% | -36.21% |
| 2021 | 35.90% | -17.74% |
| 2020 | 43.64% | 21.90% |
| 2019 | 35.80% | -2.43% |
| 2018 | 36.69% | -2.99% |
| 2017 | 37.82% | 14.47% |
| 2016 | 33.04% | -10.24% |
| 2015 | 36.81% | 3.87% |
| 2014 | 35.44% | 37.52% |
| 2013 | 25.77% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -103.16% |
US
|
|
| -149.01% | -87.82% |
US
|
|
| 25.57% | -102.09% |
AU
|
|
| 31.23% | -102.55% |
BE
|
|
| 29.35% | -102.40% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Shanghai Shen Lian Biomedical Corporation's operating margin
What is Shanghai Shen Lian Biomedical Corporation's operating margin?
Shanghai Shen Lian Biomedical Corporation's operating margin is -12.23%, as of Nov 2026.
What was Shanghai Shen Lian Biomedical Corporation's operating margin in 2025?
In 2025, Shanghai Shen Lian Biomedical Corporation's operating margin was -10.98%, compared with -18.62% in 2024.
How has Shanghai Shen Lian Biomedical Corporation's operating margin changed since 2020?
From 2020 to 2025, Shanghai Shen Lian Biomedical Corporation's operating margin was highest in 2020 (43.64%) and lowest in 2024 (-18.62%).
How does Shanghai Shen Lian Biomedical Corporation's operating margin compare with similar companies?
Shanghai Shen Lian Biomedical Corporation's operating margin (-12.23%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.